Support your sexual wellness with Addyi®, the FDA-approved, non-hormonal “Little Pink Pill” designed for premenopausal women experiencing low sexual desire associated with HSDD.
ADDYI, commonly known as the “Little Pink Pill,” is an FDA-approved oral medication available at Dermalign Medical Aesthetics in Langhorne, PA. Explicitly designed for premenopausal women, ADDYI helps treat hypoactive sexual desire disorder (HSDD), a condition characterized by a persistent lack of sexual interest that can cause personal distress. Unlike treatments that target physical issues, ADDYI works by adjusting neurotransmitters such as dopamine and serotonin in the brain, which are responsible for regulating sexual desire.
Addyi®, commonly known as the “Little Pink Pill,” is an FDA-approved oral medication designed to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD is characterized by persistently low sexual desire that causes personal distress. Unlike hormonal treatments, Addyi® is non-hormonal and works by affecting neurotransmitters in the brain, including dopamine and serotonin, which play a role in regulating sexual desire. It is taken once daily at bedtime, rather than only when needed.
Addyi® works by adjusting neurotransmitters in the brain, including dopamine and serotonin, which play an important role in sexual desire. Unlike hormonal treatments, Addyi® is a non-hormonal medication.
Addyi® is specifically designed for premenopausal women experiencing HSDD, a condition characterized by persistently low sexual desire that causes personal distress.
Many women begin noticing improvements in sexual desire within approximately 4–8 weeks of consistent daily use. Individual results may vary.
The benefits of Addyi® can continue for as long as the medication is taken consistently as prescribed. If treatment is discontinued, the benefits may gradually diminish.
Addyi® is taken once daily at bedtime. It is not an as-needed medication, so consistent daily use is important for achieving and maintaining results.
